Kalaris Therapeutics Inc KLRSNasdaq
3.94USDClose on 08/10
At a glance
Kalaris Therapeutics Inc sits in the ‘Resting’ stage of its cycle. It has moved -64.1% since its first surge signal on 2026-02-24, when the past-year gain stood at +13.9%.
- Since surge signal
- -64.1%
- First surge signal
- 2026-02-24
- Price at signal
- 10.97
- Past-year gain (at signal)
- +13.9%
- Sector
- Biotech
- Market
- US
- As of
- 2026-08-10
Start the AI analysis
No analysis has been run for this ticker today. It takes about a minute.